NAH activities @ SIOG annual conferences
You can read about the NAH activities during the SIOG Annual Conferences and about the SIOG NAH investigators award.
Pre-conference - Wednesday, November 16 - 14:00-16:45
SIOG Nursing and Allied Health (NAH) session (open to all delegates)
14:00-14:10 Introduction SIOG NAH Group
14:10-14:35 Polypharmacy practical aspects of clinical polypharmacy assessment and management Ginah Nightingale (US)
14:35-15:00 Education of oncology nursing in geriatric care Peggy Burhenn (US)
15:00-15:25 Patient engagement in research Martine Puts (CA)
15:45-16:40 Round table discussion based on group interest - All
16:40-16:45 Closing SIOG NAH Group
This award aims to recognise significant contributions from new investigators in geriatric oncology nursing and allied professions at international level. The two finalists were: Martine Puts (CA) and Fay Strohschein (CA). The SIOG 2016 Nursing & Allied Health Investigators Award will be handed out during the Presidential session on Saturday, November 19 at 11:30 in room Washington B.
The 2016 winner was
Fay Strohschein (Canada)
PhD Candidate, Nursing Clinical Consultant, McGill University, Ingram School of Nursing, Montreal, Canada
Fay Strohschein is a PhD candidate at the Ingram School of Nursing, McGill University, in Montreal, Canada. Her research interest in treatment decision making among older adults with cancer grew out of her clinical work with the Consultation Service for Senior Oncology Patients at the Jewish General Hospital, also in Montreal. She has worked as a Nursing Clinical Consultant/Nurse Navigator with this program since its inception in 2006. Throughout her studies, Fay has held fellowships with the Quebec Network for Research on Aging and the Psychosocial Oncology Research Training Program, funded by the Canadian Institutes of Health Research. Her dissertation study was funded through an Oncology Nursing Foundation (USA) Research Grant and a Fonds de recherché du Québec - Santé Doctoral Training Award.
Her abstract (O12) was presented on Saturday, November 19, 2016 at 09:45 in room Washington B.
SIOG 2015 Nursing & Allied Health Investigators Award
This award aims to recognise significant contributions from new investigators in geriatric oncology nursing and allied professions at international level. The three finalists were: Martine Puts (CA); Doris Lijsbeth van Abbema (NL) and Peggy Sue Burhenn (US).
The 2015 winner was:
Doris van Abbema
RN, PhD student
Maastricht University Medical Centre, Maastricht, The Netherlands
Doris van Abbema, RN, PhD student, is a nurse at the Maastricht University Medical Centre, The Netherlands since 2008.
She worked on the Breast Centre of the Maastricht University Medical Centre and participated in several projects, among a project to implement an individualized care plan for breast cancer patients and to evaluate the care of young breast cancer patients with fertility concerns.
In 2011 she graduated as health scientist at the Maastricht University after which she started her PhD on treatment outcomes in older cancer patients. She collaborated in the KLIMOP research group, which is a longitudinal cohort study on the long-term outcomes of older cancer patients. This study was performed in Belgium and the Netherlands.
The three finalists were Cindy Kenis (Belgium), Ginah Nightingale (US) and Heidi Yulico (US).
The 2014 winner was:
Geriatric Oncology Nurse
UZ Leuven, Leuven, Belgium
Cindy Kenis has achieved her Bachelor degree in Nursing at KH Leuven (2002) and her Master in Nursing Science at KU Leuven (2005), Belgium.
As a geriatric oncology nurse, she is coordinating the largest multicentric studies within the Belgian Cancer Plan (CP) (CP 2009-2011: 10 centres; CP 2012-2015: 22 centres) focusing on the systematic implementation of geriatric screening and assessment in older patients with cancer, followed by geriatric recommendations / interventions and follow-up. Based on her experience, she started a PhD in 2013 within the field of geriatric oncology with the title: ‘Geriatric screening and assessment in older cancer patients’.